Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Gross Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed Gross Margin for 8 consecutive years, with 92.04% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin rose 245.0% to 92.04% in Q3 2025 year-over-year; TTM through Sep 2025 was 92.6%, a 213.0% increase, with the full-year FY2024 number at 90.0%, down 321.0% from a year prior.
  • Gross Margin was 92.04% for Q3 2025 at Catheter Precision, down from 93.4% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 95.49% in Q3 2023 to a low of 11075.0% in Q1 2021.
  • A 5-year average of 1002.12% and a median of 89.58% in 2024 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: plummeted -1105972bps in 2021, then skyrocketed 1011944bps in 2022.
  • Catheter Precision's Gross Margin stood at 56.35% in 2021, then tumbled by -2265bps to 1220.0% in 2022, then skyrocketed by 108bps to 94.53% in 2023, then decreased by -2bps to 92.62% in 2024, then decreased by -1bps to 92.04% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Gross Margin are 92.04% (Q3 2025), 93.4% (Q2 2025), and 92.31% (Q1 2025).